Researchers have suggested that exposure to Listeria may pose a greater risk of complications in early pregnancy than previously appreciated.
Browsing: Disease Area > Bacterial
Rapid diagnostic tests for detecting emerging antibiotic resistance are mostly available and should be used now state authors Patrice Nordmann and Laurent Poirel (University of Fribourg, Switzerland). This exclusive opinion piece discusses available diagnostics and why we should take action.
Researchers have created a model to assess the benefits of vaccination on the burden of non-typhoidal salmonella in Mali; the research could inform policy in many countries where there is high risk of these infections.
A study including over 10,000 patients has demonstrated a lower risk of all-cause 30-day mortality when Clostridium difficile infections are treated with vancomycin as opposed to metronidazole.
This study evaluates the direct high-throughput multiple genetic detection system for H. pylori in gastric biopsy samples. Could this method efficiently diagnose and quantify H. pylori burden? And does it have the capacity to screen for virulence, antibiotic resistance and multistrain infections?
Could probiotics be used to treat Enterotoxigenic Escherichia coli (ETEC)? This review discusses ETEC pathogenesis, its modulation by human gastrointestinal cues and novel preventive strategies such as probiotics.
In this study the authors delve into fighting antibiotic resistance, aiming to synthesize and evaluate the antimicrobial activity of a new series of quinazolinone azolyl ethanols .
Researchers have discovered that a component of the Staphylococcus aureus cell wall appears to be responsible for elevated virulence in community-associated MRSA infections. This mechanism could present a target for novel anti-infective strategies.
This editorial discusses the role of metabolomics in identifying TB biomarkers, which have shed light on previously unknown disease mechanisms and could contribute to improved TB diagnostics.
This perspective discusses the urgent need for novel and efficient antimicrobial strategies against C. difficile and the authors evaluate the application of the acyldepsipeptides family of antibiotics to treat C. difficile infections.